Uwe Heilenkötter
Klinikum Itzehoe(DE)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Cancer-related Molecular Pathways, Breast Cancer Treatment Studies, Cancer Cells and Metastasis, Protease and Inhibitor Mechanisms
Most-Cited Works
- → Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer(2012)65 cited
- → High levels of class III β-tubulin expression are associated with aggressive tumor features in breast cancer(2016)56 cited
- → Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer(2019)49 cited
- → High homogeneity of MMR deficiency in ovarian cancer(2020)46 cited
- → Partial PTEN deletion is linked to poor prognosis in breast cancer(2015)44 cited
- → p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer(2016)44 cited
- → Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome(2010)43 cited
- → Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer(2009)36 cited
- → Cyclin D1 gene amplification is highly homogeneous in breast cancer(2014)35 cited
- → 8p deletion is strongly linked to poor prognosis in breast cancer(2015)34 cited